中国医学创新
中國醫學創新
중국의학창신
MEDICAL INNOVATION OF CHINA
2015年
22期
139-141,142
,共4页
内窥镜检查%额窦%鼻丘%手术
內窺鏡檢查%額竇%鼻丘%手術
내규경검사%액두%비구%수술
Endoscopy%Frontal sinus%Agger nasi cell%Surgery
目的:探讨鼻内镜下鼻丘径路额窦开放术治疗额窦病变的方法及疗效。方法:回顾性分析40例(69侧)鼻内镜下鼻丘径路额窦开放术治疗额窦病变患者的临床资料。根据病变性质、术前CT检查及术中所见决定行DraftⅠ型或DraftⅡb型额窦开放术。结果:所有患者随访6~12个月,治愈49侧(71.0%),有效17侧(24.6%),无效3侧(4.4%),无严重并发症。结论:鼻内镜下鼻丘径路治疗额窦病变是一种术野宽敞、操作容易、安全性高、疗效确切的方法。
目的:探討鼻內鏡下鼻丘徑路額竇開放術治療額竇病變的方法及療效。方法:迴顧性分析40例(69側)鼻內鏡下鼻丘徑路額竇開放術治療額竇病變患者的臨床資料。根據病變性質、術前CT檢查及術中所見決定行DraftⅠ型或DraftⅡb型額竇開放術。結果:所有患者隨訪6~12箇月,治愈49側(71.0%),有效17側(24.6%),無效3側(4.4%),無嚴重併髮癥。結論:鼻內鏡下鼻丘徑路治療額竇病變是一種術野寬敞、操作容易、安全性高、療效確切的方法。
목적:탐토비내경하비구경로액두개방술치료액두병변적방법급료효。방법:회고성분석40례(69측)비내경하비구경로액두개방술치료액두병변환자적림상자료。근거병변성질、술전CT검사급술중소견결정행DraftⅠ형혹DraftⅡb형액두개방술。결과:소유환자수방6~12개월,치유49측(71.0%),유효17측(24.6%),무효3측(4.4%),무엄중병발증。결론:비내경하비구경로치료액두병변시일충술야관창、조작용역、안전성고、료효학절적방법。
Objective:To explore the feasibility and clinical effect of endoscopic frontal sinus surgery through the agger nasi cell approach. Method:A retrospective study of 40 patitents(69 sides)with frontal sinus diseases treated with the agger nasi cell approach was performed. We selected DraftⅠor DraftⅡb frontal sinus drainage according to the nature,CT scan and intraoperative findings. Result:All the patients were followed up for 6-12 months.49 sides(71.0%)were completely healed, 17 sides(24.6%)were improved and 3 sides(4.4%)failed. No severe complication occurred. Conclusion:The agger nasi cell approach is an efficient and safe method for the treatment of frontal sinus diseases,and can provide wide visualization.